| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Radiation Oncology [D. M. B., T. V. S., L. R. P., M. W. D.], Pathology [L. J. L.], and Radiology [H. C. C.] and Divisions of Orthopedics, Department of Surgery [S. P. S., J. M. H.] and Biometry, Department of Community and Family Medicine [R. K. D.], Duke University Comprehensive Cancer Center, Durham, North Carolina 27710
The adverse prognostic impact of tumor hypoxia has been demonstrated in human malignancy. We report the effects of radiotherapy and hyperthermia (HT) on soft tissue sarcoma oxygenation and the relationship between treatment-induced changes in oxygenation and clinical treatment outcome. Patients receiving preoperative radiotherapy and HT underwent tumor oxygenation measurement pretreatment after the start of radiation/pre-HT and one day after the first HT treatment. The magnitude of improvement in tumor oxygenation after the first HT fraction relative to pretreatment baseline was positively correlated with the amount of necrosis seen in the resection specimen. Patients with <90% resection specimen necrosis experienced longer disease-free survival than those with
90% necrosis. Increasing levels of tumor hypoxia were also correlated with diminished metabolic status as measured by P-31 magnetic resonance spectroscopy.
1 Supported by NIH Grant P01 CA42745.
2 To whom requests for reprints should be addressed, at Department of Radiation Oncology, Box 3085, Duke University Medical Center, Durham, NC 27710. Phone: (919) 660-2119; Fax: (919) 684-3953.
Received 8/19/96. Accepted 10/16/96.
This article has been cited by other articles:
![]() |
D. S. Coffey, R. H. Getzenberg, and T. L. DeWeese Hyperthermic biology and cancer therapies: a hypothesis for the "Lance Armstrong effect". JAMA, July 26, 2006; 296(4): 445 - 448. [Full Text] [PDF] |
||||
![]() |
S. L. Gibson, R. S. Bindra, and P. M. Glazer Hypoxia-Induced Phosphorylation of Chk2 in an Ataxia Telangiectasia Mutated-Dependent Manner Cancer Res., December 1, 2005; 65(23): 10734 - 10741. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Thrall, S. M. LaRue, D. Yu, T. Samulski, L. Sanders, B. Case, G. Rosner, C. Azuma, J. Poulson, A. F. Pruitt, et al. Thermal Dose Is Related to Duration of Local Control in Canine Sarcomas Treated with Thermoradiotherapy Clin. Cancer Res., July 15, 2005; 11(14): 5206 - 5214. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Bindra, P. J. Schaffer, A. Meng, J. Woo, K. Maseide, M. E. Roth, P. Lizardi, D. W. Hedley, R. G. Bristow, and P. M. Glazer Down-Regulation of Rad51 and Decreased Homologous Recombination in Hypoxic Cancer Cells Mol. Cell. Biol., October 1, 2004; 24(19): 8504 - 8518. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Zakian, A. Shukla-Dave, P. Meyers, R. Gorlick, J. Healey, H. T. Thaler, A. G. Huvos, D. M. Panicek, and J. A. Koutcher Identification of Prognostic Markers in Bone Sarcomas Using Proton-Decoupled Phosphorus Magnetic Resonance Spectroscopy Cancer Res., December 15, 2003; 63(24): 9042 - 9047. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Boedefeld II, K. I. Bland, and M. J. Heslin Recent Insights Into Angiogenesis, Apoptosis, Invasion, and Metastasis in Colorectal Carcinoma Ann. Surg. Oncol., October 1, 2003; 10(8): 839 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imai, A. Horiuchi, C. Wang, K. Oka, S. Ohira, T. Nikaido, and I. Konishi Hypoxia Attenuates the Expression of E-Cadherin via Up-Regulation of SNAIL in Ovarian Carcinoma Cells Am. J. Pathol., October 1, 2003; 163(4): 1437 - 1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Coleman, J. B. Mitchell, and K. Camphausen Tumor Hypoxia: Chicken, Egg, or a Piece of the Farm? J. Clin. Oncol., February 1, 2002; 20(3): 610 - 615. [Full Text] [PDF] |
||||
![]() |
K. Ozaki, J. K. Haseman, J. R. Hailey, R. R. Maronpot, and A. Nyska Association of Adrenal Pheochromocytoma and Lung Pathology in Inhalation Studies with Particulate Compounds in the Male F344 Rat--The National Toxicology Program Experience Toxicol Pathol, February 1, 2002; 30(2): 263 - 270. [Abstract] [PDF] |
||||
![]() |
E. Cohen-Jonathan, S. M. Evans, C. J. Koch, R. J. Muschel, W. G. McKenna, J. Wu, and E. J. Bernhard The Farnesyltransferase Inhibitor L744,832 Reduces Hypoxia in Tumors Expressing Activated H-ras Cancer Res., March 1, 2001; 61(5): 2289 - 2293. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |